Thromb Haemost 1962; 07(03): 470-479
DOI: 10.1055/s-0038-1655396
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Thromboplastinase — an Experimental Anti-thrombotic[*]

S Gollub
1   Samuel P. Mandell Laboratory, Department of Surgery, Einstein Medical Center — Southern Division, and the Sidney Hillman Medical Center, Philadelphia, Penna
,
A. C Ottolenghi
1   Samuel P. Mandell Laboratory, Department of Surgery, Einstein Medical Center — Southern Division, and the Sidney Hillman Medical Center, Philadelphia, Penna
,
J. R Rutman
1   Samuel P. Mandell Laboratory, Department of Surgery, Einstein Medical Center — Southern Division, and the Sidney Hillman Medical Center, Philadelphia, Penna
,
L Lisbinsky
1   Samuel P. Mandell Laboratory, Department of Surgery, Einstein Medical Center — Southern Division, and the Sidney Hillman Medical Center, Philadelphia, Penna
,
A. W Ulin
1   Samuel P. Mandell Laboratory, Department of Surgery, Einstein Medical Center — Southern Division, and the Sidney Hillman Medical Center, Philadelphia, Penna
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
21. Juni 2018 (online)

Summary

The enzyme thromboplastinase — a phospholipase elaborated by Bacillus cereus has been shown to be an effective antithrombotic in the experimental animal. Present impure preparations of this enzyme are well tolerated by the experimental animal and its quantitative presence in circulating blood has been detected at least 2 days after a single intravenous injection. The effects of this enzyme on the blood coagulation mechanism, methods of assay, and its possible biochemical mode of action as an antithrombotic are discussed.

* Supported in part by grant C 4546 and E 3701 from the National Institutes of Health.


 
  • References

  • 1 Gollub S, Kaplan F. E, Meranze D. R. Thromboplastic Potency Changes a Result of Bacterial Action. Proc. Soc. exp. Biol. (N. Y.) 1950; 70: 725
  • 2 Gollub S, Feldman D, Schechter D, Kaplan F. E, Meranze D. R. Thromboplastinase a New Enzyme Which Destroys Thromboplastin. Proc. Soc. exp. Biol. (N. Y.) 1953; 83: 858
  • 3 Gollub S. Action of Thromboplastinase on Human Blood Thromboplastin. J. appl. Physiol 1955; 7: 409
  • 4 Schecter D, Kaplan F. E, Feldman D, Gollub S, Meranze D. R. Prevention of Toxic Effects of Injected Thromboplastin by "Thromboplastinase". Proc. Soc. exp. Biol. (N. Y.) 1953; 84: 375
  • 5 Ottolenghi A. C, Rutman J, Gollub S, Ulin A. W. Thromboplastinase as an Antithrombotic Agent. Fed. Proc. March. 1961
  • 6 Ottolenghi A. C, Gollub S, Ulin A. W. Studies on Phospholipase from Bacillus cereus 1 — Separation of Phospholypolytic and Hemolytic Activities. Bact. Proc. 1961: 171
  • 7 Gollub S, Ottolenghi A. C, Lisbinsky L, Ulin A. W. Thromboplastinase — a Phospholipase from Bacillus cereus(submitted for publication)
  • 8 Gollub S, Ottolenghi A. C, Lisbinsky L, Ulin A. W. The Potency of Tissue Thromboplastic Suspensions. Thromb. Diath. haem 1962; 7: 95
  • 9 Litchfield Jr. J. F, Wilcoxon F. Simplified Method of Evaluating Dose-Effect Experiments. J. Pharmacol. exp. Ther 1949; 96: 2
  • 10 Page R. C, de Beer E. J, Orr M. L. Prothrombin Studies Using Russel Viper Venom. J. Lab. clin. Med 1941; 27: 197
  • 11 Quick A. J. The Hemorrhagic Disease and the Physiology of Hemostasis . Ill; Thomas, Springfield: 1942
  • 12 Biggs R, MacFarlane R. G. Human Blood Coagulation and its Disorders . Ill., Thomas; Springfield: 1957
  • 13 Tocantins L. The Coagulation of Blood — Methods of Study . Gruve and Straiten, N. Y; New York: 1955
  • 14 Storm O. Prevention of Thromboplastinase Induced Thrombosis In Rabbits By Means of Plasmin. Thromb. Diath. haem 1959; 3: 20